Bayer Pharmaceuticals Corp. has named Derek Toomre, assistant professor in the Department of Cell Biology at Yale School of Medicine, the Bayer Fellow in Medicine and Management for 2005-2006. He’s also Assistant Member, Ludwig Institute for Cancer...
Patients who are delirious during hospitalization one year later had 13 percent fewer days of survival during the following year when compared to patients without delirium, according to a study published this month in the Archives of Internal Medicine....
Yale School of Medicine is the recipient of a $6.5 million grant from the National Institutes of Health (NIH) to establish a microarray center for research on the nervous system.The Yale center is a new addition to the NIH Neuroscience Microarray...
Yale School of Medicine is participating in the first clinical trial testing atorvastatin to delay or decrease disease in patients who have experienced a first attack of multiple sclerosis (MS).Statins, of which atorvastatin is one, are a relatively new...
July 12, 2005 — A Yale School of Medicine-based, multi-institutional study on necrotizing enterocolitis (NEC) is being supported by a $1 million grant from the Gerber Foundation. NEC is an acute intestinal condition occurring in premature and low birth...
July 12, 2005 — Yale School of Medicine researchers report the first demonstration that a single mutation in a human sodium channel gene can trigger pain in people with an inherited pain syndrome known as primary erythromelalgia, according to a study...
July 11, 2005 — Researchers have pinpointed specific gene and protein over-production in metastatic melanoma, pointing the way to a possible new drug target, according to a study published in Nature July 7. Gene amplification is a process that often...
July 8, 2005 — Yale School of Nursing (YSN) has moved from 48th to sixth among nursing schools nationwide in support from the National Institutes of Health (NIH) for research, training and fellowship activities, according to rankings released recently by...
July 8, 2005 — Yale School of Medicine is recruiting patients with Alzheimer’s disease to test a vaccine that appears to slow the accumulation of beta amyloid plaque in the brain. Alzheimer’s, which is marked by a progressive loss of mental ability and...